The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh

BACKGROUND: The curfews and lockdowns imposed during the COVID-19 pandemic may decreased the volume of traffic and reduced air pollution. In addition, social distancing measures may contribute to reducing infection and asthma exacerbation.OBJECTIVE: The objective of this study was to assess asthma c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Khan Mohammad Ayaz, Rajendram Rajkumar, Al-Ghamdi Basma, Al-Jahdaly Emad, AL-Harbi Abdullah, Hayyan Hajar, Obaidi Mostafa Mohammad, Hamdan AL-Jahdali
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2021
Materias:
Acceso en línea:https://doaj.org/article/2da85f2ceb4a485391632b9291a08961
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2da85f2ceb4a485391632b9291a08961
record_format dspace
spelling oai:doaj.org-article:2da85f2ceb4a485391632b9291a089612021-11-12T10:08:17ZThe effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh1817-17371998-355710.4103/atm.atm_559_20https://doaj.org/article/2da85f2ceb4a485391632b9291a089612021-01-01T00:00:00Zhttp://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2021;volume=16;issue=4;spage=354;epage=360;aulast=Ayazhttps://doaj.org/toc/1817-1737https://doaj.org/toc/1998-3557BACKGROUND: The curfews and lockdowns imposed during the COVID-19 pandemic may decreased the volume of traffic and reduced air pollution. In addition, social distancing measures may contribute to reducing infection and asthma exacerbation.OBJECTIVE: The objective of this study was to assess asthma control and asthma medication use among severe asthmatics on biologics before and after the COVID-19 pandemic.METHODS: This is a cross-sectional survey study of patients with severe asthma receiving biologic therapy at King Abdulaziz Medical City-Riyadh, Saudi Arabia. We looked at the effects of the COVID-19 lockdown on this cohort of severe asthmatics on biologic therapy from March till June 2020 over a period of 12 weeks. We investigated changes in patients' symptoms and asthma control using the asthma control test (ACT) score and other parameters including emergency department visits, hospitalizations, use of oral prednisolone, changes in inhaler therapy, frequency of bronchodilator use, and patient perception of their symptoms before and after the lockdown period.RESULTS: A total of 56, Female 39 (69%), mean age ± SD 47.4 ± 13.8 years. The duration of bronchial asthma since diagnosis ranged from 4 to 30 years. Most patients had been treated with omalizumab (47, 84%); the rest received mepolizumab (7, 12.5%) and dupilumab (2, 3.6%). All these patients had been on biologic therapy for 5 months, ranging from 5 to 120 months. Most of the patients (45, 80.4%) agreed that their symptoms of asthma had improved with biologic therapy. Most of the patients felt that overall asthma symptoms are better after curfew and lockdown 28 (50%). Less use of bronchodilators postcurfew was reported in 38% of the patients. Asthma control (≥20) using ACT score was significantly higher among patients in postcurfew and lockdown period compared to precurfew period 34 (61.7%) and 23 (41%) (P = 0.001), respectively.CONCLUSIONS: Asthma control was better postcurfew and lockdown. A decrease in air pollution and social distances may be a contributing factor.Khan Mohammad AyazRajendram RajkumarAl-Ghamdi BasmaAl-Jahdaly EmadAL-Harbi AbdullahHayyan HajarObaidi Mostafa MohammadHamdan AL-JahdaliWolters Kluwer Medknow Publicationsarticlebiologicscovid-19severe asthmaDiseases of the circulatory (Cardiovascular) systemRC666-701Diseases of the respiratory systemRC705-779ENAnnals of Thoracic Medicine, Vol 16, Iss 4, Pp 354-360 (2021)
institution DOAJ
collection DOAJ
language EN
topic biologics
covid-19
severe asthma
Diseases of the circulatory (Cardiovascular) system
RC666-701
Diseases of the respiratory system
RC705-779
spellingShingle biologics
covid-19
severe asthma
Diseases of the circulatory (Cardiovascular) system
RC666-701
Diseases of the respiratory system
RC705-779
Khan Mohammad Ayaz
Rajendram Rajkumar
Al-Ghamdi Basma
Al-Jahdaly Emad
AL-Harbi Abdullah
Hayyan Hajar
Obaidi Mostafa Mohammad
Hamdan AL-Jahdali
The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
description BACKGROUND: The curfews and lockdowns imposed during the COVID-19 pandemic may decreased the volume of traffic and reduced air pollution. In addition, social distancing measures may contribute to reducing infection and asthma exacerbation.OBJECTIVE: The objective of this study was to assess asthma control and asthma medication use among severe asthmatics on biologics before and after the COVID-19 pandemic.METHODS: This is a cross-sectional survey study of patients with severe asthma receiving biologic therapy at King Abdulaziz Medical City-Riyadh, Saudi Arabia. We looked at the effects of the COVID-19 lockdown on this cohort of severe asthmatics on biologic therapy from March till June 2020 over a period of 12 weeks. We investigated changes in patients' symptoms and asthma control using the asthma control test (ACT) score and other parameters including emergency department visits, hospitalizations, use of oral prednisolone, changes in inhaler therapy, frequency of bronchodilator use, and patient perception of their symptoms before and after the lockdown period.RESULTS: A total of 56, Female 39 (69%), mean age ± SD 47.4 ± 13.8 years. The duration of bronchial asthma since diagnosis ranged from 4 to 30 years. Most patients had been treated with omalizumab (47, 84%); the rest received mepolizumab (7, 12.5%) and dupilumab (2, 3.6%). All these patients had been on biologic therapy for 5 months, ranging from 5 to 120 months. Most of the patients (45, 80.4%) agreed that their symptoms of asthma had improved with biologic therapy. Most of the patients felt that overall asthma symptoms are better after curfew and lockdown 28 (50%). Less use of bronchodilators postcurfew was reported in 38% of the patients. Asthma control (≥20) using ACT score was significantly higher among patients in postcurfew and lockdown period compared to precurfew period 34 (61.7%) and 23 (41%) (P = 0.001), respectively.CONCLUSIONS: Asthma control was better postcurfew and lockdown. A decrease in air pollution and social distances may be a contributing factor.
format article
author Khan Mohammad Ayaz
Rajendram Rajkumar
Al-Ghamdi Basma
Al-Jahdaly Emad
AL-Harbi Abdullah
Hayyan Hajar
Obaidi Mostafa Mohammad
Hamdan AL-Jahdali
author_facet Khan Mohammad Ayaz
Rajendram Rajkumar
Al-Ghamdi Basma
Al-Jahdaly Emad
AL-Harbi Abdullah
Hayyan Hajar
Obaidi Mostafa Mohammad
Hamdan AL-Jahdali
author_sort Khan Mohammad Ayaz
title The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
title_short The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
title_full The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
title_fullStr The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
title_full_unstemmed The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
title_sort effects of the covid-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in riyadh
publisher Wolters Kluwer Medknow Publications
publishDate 2021
url https://doaj.org/article/2da85f2ceb4a485391632b9291a08961
work_keys_str_mv AT khanmohammadayaz theeffectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT rajendramrajkumar theeffectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT alghamdibasma theeffectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT aljahdalyemad theeffectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT alharbiabdullah theeffectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT hayyanhajar theeffectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT obaidimostafamohammad theeffectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT hamdanaljahdali theeffectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT khanmohammadayaz effectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT rajendramrajkumar effectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT alghamdibasma effectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT aljahdalyemad effectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT alharbiabdullah effectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT hayyanhajar effectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT obaidimostafamohammad effectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
AT hamdanaljahdali effectsofthecovid19lockdownonsevereasthmainpatientstakingbiologictherapyandairpollutioninriyadh
_version_ 1718431039403065344